Turners Syndrome in Females- An Updated Overview

Speciality: Pediatrics


Speaker:

Dr. Jayashree Gopal | Diplomate of the American Board in Internal Medicine, Endocrinology and Diabetes Director, DiabEndoIndia Institute for Diabetes, Endocrinology, Lifestyle and Metabolic Health Senior Consultant Endocrinologist and Diabetologist

Dr. Usha Sriram | Graduate of Madras Medical College MBBS, AB Internal medicine and AB Endocrinology Diabetes and Metabolism

Description:

A warm welcome to all the medical professionals in this interesting session of Turner syndrome management in female patients. In this webinar, the speakers, Dr. Jayashree Gopal, and Dr. Usha Sriram has shared the important facts associated with Turner syndrome . 

Turner syndrome is a growth deficit condition that affects only females. It occurs when one of the X chromosomes (sex chromosomes) is missing or partially missing in females. Turner syndrome can cause a variety of medical and developmental problems, including short height, failure of the ovaries to develop and heart defects.

As it is a chromosomal condition Turner syndrome can affect development in females. The most common feature observed in Turner syndrome is short stature, which becomes evident by about age 5. An early loss of ovarian function (ovarian hypofunction or premature ovarian failure) is most commonly seen.

Therefore,  you are going to have an overall knowledge regarding Turner syndrome. Listen to the webinar, grab the knowledge that is shared and follow HiDoc for more such interesting webinar sessions.


See More Webinars @ Hidoc Webinars




Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

'Chemo brain' cognitive issues linked to poor lymphatic-system drainage

2.

AI System Beats Radiologists in Detecting Clinically Significant Prostate Cancer

3.

A consensus statement from researchers on the proper use of Lu-177 PSMA-617 radionuclide therapy and patient selection is published.

4.

According to JAMA, 5 alpha-reductase inhibitors are not significantly linked to prostate cancer mortality.

5.

Researchers can now forecast how prostate cancer bone metastases will react to radium-223 treatment.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot